Prostaglandin E1 Agonist [EPC]

Prostaglandin E1 Agonist [EPC] was reported 3625 times

These side effects are most commonly reported by patients taking drugs of the Prostaglandin E1 Agonist [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 888
1 OFF LABEL USE 161
2 ERECTION INCREASED 136
3 ERECTILE DYSFUNCTION 93
4 INJECTION SITE PAIN 92
5 PRODUCT QUALITY ISSUE 92
6 PENILE PAIN 88
7 PYREXIA 87
8 HAEMOGLOBIN DECREASED 83
9 PAIN 82
10 PRIAPISM 81
11 LYMPHOCYTE COUNT DECREASED 79
12 DIARRHOEA 77
13 CARDIAC FAILURE 74
14 DRUG EFFECT DECREASED 73
15 CONDITION AGGRAVATED 70
16 BLOOD GLUCOSE INCREASED 65
17 ANAEMIA 60
18 BLOOD UREA INCREASED 59
19 DEVICE MALFUNCTION 55
20 NEUTROPHIL COUNT INCREASED 54
21 PNEUMONIA 52
22 HEADACHE 51
23 WHITE BLOOD CELL COUNT INCREASED 51
24 DRUG INTERACTION 50
25 INCORRECT DOSE ADMINISTERED 50
26 NEEDLE ISSUE 49
27 PAINFUL ERECTION 47
28 DIZZINESS 46
29 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 46
30 NAUSEA 44
31 DYSPNOEA 43
32 INCISION SITE PAIN 43
33 PLATELET COUNT DECREASED 43
34 VOMITING 43
35 BLOOD CREATININE INCREASED 41
36 PRODUCT USE IN UNAPPROVED INDICATION 40
37 ALANINE AMINOTRANSFERASE INCREASED 39
38 DIABETES MELLITUS 39
39 HYPERTENSION 39
40 HYPOTENSION 39
41 DEATH 38
42 PENIS DISORDER 38
43 PAIN IN EXTREMITY 37
44 PRODUCT USE ISSUE 37
45 URINARY TRACT INFECTION 37
46 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 36
47 INJECTION SITE HAEMORRHAGE 36
48 PROSTATE CANCER 36
49 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36
50 MYOCARDIAL INFARCTION 35
51 C-REACTIVE PROTEIN INCREASED 34
52 HYPOKALAEMIA 34
53 CYTOMEGALOVIRUS VIRAEMIA 33
54 RED BLOOD CELLS URINE POSITIVE 33
55 CEREBROVASCULAR ACCIDENT 31
56 DEPRESSION 31
57 FATIGUE 31
58 PLEURAL EFFUSION 31
59 PROCEDURAL PAIN 31
60 ANXIETY 30
61 PROTEIN URINE PRESENT 30
62 WRONG TECHNIQUE IN DRUG USAGE PROCESS 30
63 DRUG EFFECT INCOMPLETE 29
64 MALAISE 29
65 OVERDOSE 29
66 RENAL FAILURE 29
67 ASTHENIA 28
68 BLOOD CHOLESTEROL INCREASED 28
69 CHEST DISCOMFORT 28
70 HEPATIC FUNCTION ABNORMAL 28
71 INFECTION 28
72 PULMONARY OEDEMA 28
73 SEPSIS 28
74 DEVICE FAILURE 27
75 RASH 27
76 ATRIAL FIBRILLATION 26
77 BACK PAIN 26
78 GASTROINTESTINAL INFECTION 26
79 WHITE BLOOD CELL COUNT DECREASED 26
80 CHEST PAIN 24
81 COUGH 24
82 FALL 24
83 HAEMORRHAGE 24
84 LOSS OF CONSCIOUSNESS 24
85 PRURITUS 24
86 THERAPEUTIC PRODUCT EFFECT DECREASED 24
87 ABDOMINAL DISTENSION 23
88 ASPARTATE AMINOTRANSFERASE INCREASED 23
89 BLOOD PRESSURE DECREASED 23
90 BLOOD PRESSURE INCREASED 23
91 HYPERSENSITIVITY 23
92 OXYGEN SATURATION DECREASED 23
93 SYRINGE ISSUE 23
94 VISUAL IMPAIRMENT 23
95 CONSTIPATION 22
96 INJURY ASSOCIATED WITH DEVICE 22
97 INTENTIONAL PRODUCT USE ISSUE 22
98 LUNG INFECTION 22
99 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22
100 BLOOD ALBUMIN DECREASED 21
101 BLOOD ALKALINE PHOSPHATASE INCREASED 21
102 CYSTITIS HAEMORRHAGIC 21
103 DISSEMINATED INTRAVASCULAR COAGULATION 21
104 ERYTHEMA 21
105 HYPOAESTHESIA 21
106 RENAL IMPAIRMENT 21
107 SYNCOPE 21
108 ARTHRALGIA 20
109 CHRONIC KIDNEY DISEASE 20
110 HAEMATOTOXICITY 20
111 RESPIRATORY FAILURE 20
112 APNOEA 19
113 CHILLS 19
114 CONFUSIONAL STATE 19
115 DEVICE BREAKAGE 19
116 DRUG-INDUCED LIVER INJURY 19
117 DYSURIA 19
118 HAEMATURIA 19
119 INSOMNIA 19
120 MEDICATION ERROR 19
121 MUSCLE SPASMS 19
122 PENILE HAEMORRHAGE 19
123 ARRHYTHMIA 18
124 ASCITES 18
125 DEVICE LEAKAGE 18
126 DISCOMFORT 18
127 DRUG ADMINISTRATION ERROR 18
128 DRUG HYPERSENSITIVITY 18
129 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18
130 GENERALISED OEDEMA 18
131 INTERSTITIAL LUNG DISEASE 18
132 PALPITATIONS 18
133 PRODUCT PRESCRIBING ERROR 18
134 SEIZURE 18
135 TOXIC EPIDERMAL NECROLYSIS 18
136 BLOOD TRIGLYCERIDES INCREASED 17
137 CONTUSION 17
138 DEVICE ISSUE 17
139 HEPATIC ENZYME INCREASED 17
140 KIDNEY TRANSPLANT REJECTION 17
141 LIVER DISORDER 17
142 OEDEMA PERIPHERAL 17
143 PENILE SWELLING 17
144 PHARMACEUTICAL PRODUCT COMPLAINT 17
145 PREMATURE BABY 17
146 THROMBOCYTOPENIA 17
147 ACUTE KIDNEY INJURY 16
148 CARDIAC ARREST 16
149 CARDIAC FAILURE CONGESTIVE 16
150 COMPLICATIONS OF TRANSPLANTED KIDNEY 16
151 EXPIRED PRODUCT ADMINISTERED 16
152 GASTROINTESTINAL DISORDER 16
153 HEART RATE INCREASED 16
154 INFANTILE APNOEA 16
155 NECROSIS 16
156 PENILE CURVATURE 16
157 PRODUCT STORAGE ERROR 16
158 PULMONARY EMBOLISM 16
159 SHOCK 16
160 THERAPY NON-RESPONDER 16
161 TREMOR 16
162 BLOOD BILIRUBIN INCREASED 15
163 CAESAREAN SECTION 15
164 GASTROINTESTINAL HAEMORRHAGE 15
165 HYPERLIPIDAEMIA 15
166 INTENTIONAL PRODUCT MISUSE 15
167 SEPTIC SHOCK 15
168 SKIN ULCER 15
169 WEIGHT DECREASED 15
170 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 14
171 APNOEIC ATTACK 14
172 ARTERIOSCLEROSIS 14
173 BRADYCARDIA 14
174 HAEMOPTYSIS 14
175 INFANTILE APNOEIC ATTACK 14
176 ISCHAEMIC STROKE 14
177 LEUKOPENIA 14
178 MUSCULAR WEAKNESS 14
179 NEUTROPENIA 14
180 SEXUAL DYSFUNCTION 14
181 TESTICULAR PAIN 14
182 BILIRUBIN CONJUGATED INCREASED 13
183 CAPILLARY LEAK SYNDROME 13
184 CORONARY ARTERY DISEASE 13
185 DEEP VEIN THROMBOSIS 13
186 DRUG DEPENDENCE 13
187 FEELING ABNORMAL 13
188 FLUSHING 13
189 MEMORY IMPAIRMENT 13
190 MYALGIA 13
191 MYOCARDIAL ISCHAEMIA 13
192 PARAESTHESIA 13
193 POST PROCEDURAL COMPLICATION 13
194 PREGNANCY 13
195 THROMBOSIS 13
196 URINARY RETENTION 13
197 WEIGHT INCREASED 13
198 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 13
199 ABDOMINAL PAIN 12
200 ABDOMINAL PAIN UPPER 12
201 ACUTE GRAFT VERSUS HOST DISEASE 12
202 ANGINA PECTORIS 12
203 BURNING SENSATION 12
204 CELLULITIS 12
205 CEREBRAL INFARCTION 12
206 COAGULOPATHY 12
207 DRUG EXPOSURE DURING PREGNANCY 12
208 GAIT DISTURBANCE 12
209 HYPERHIDROSIS 12
210 LUNG DISORDER 12
211 NO ADVERSE EVENT 12
212 PENILE BURNING SENSATION 12
213 PENILE SIZE REDUCED 12
214 PRODUCT DISPENSING ERROR 12
215 PROSTATIC OPERATION 12
216 UPPER RESPIRATORY TRACT INFECTION 12
217 BLOOD URINE PRESENT 11
218 CYTOMEGALOVIRUS INFECTION 11
219 DECREASED APPETITE 11
220 DRUG EFFECT LESS THAN EXPECTED 11
221 EMOTIONAL DISTRESS 11
222 END STAGE RENAL DISEASE 11
223 ENTEROCOLITIS 11
224 EXPIRED DRUG ADMINISTERED 11
225 GENERAL PHYSICAL HEALTH DETERIORATION 11
226 HYPOACUSIS 11
227 HYPOALBUMINAEMIA 11
228 INCORRECT DOSE ADMINISTERED BY DEVICE 11
229 INFANTILE CORTICAL HYPEROSTOSIS 11
230 LOW DENSITY LIPOPROTEIN INCREASED 11
231 MUSCULOSKELETAL PAIN 11
232 NEOPLASM MALIGNANT 11
233 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11
234 PEYRONIE^S DISEASE 11
235 STOMATITIS 11
236 SWELLING 11
237 TACHYCARDIA 11
238 UNDERDOSE 11
239 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 10
240 AMNESIA 10
241 BLOOD CREATINE PHOSPHOKINASE INCREASED 10
242 BODY TEMPERATURE INCREASED 10
243 CEREBRAL HAEMORRHAGE 10
244 CONVULSION 10
245 DEPRESSED LEVEL OF CONSCIOUSNESS 10
246 DEVICE MECHANICAL ISSUE 10
247 DISEASE PROGRESSION 10
248 DRUG PRESCRIBING ERROR 10
249 EPILEPSY 10
250 FOREIGN BODY IN REPRODUCTIVE TRACT 10
251 FUNGAL INFECTION 10
252 GANGRENE 10
253 HIGH DENSITY LIPOPROTEIN DECREASED 10
254 INJECTION SITE HAEMATOMA 10
255 INTENTIONAL DRUG MISUSE 10
256 PATENT DUCTUS ARTERIOSUS 10
257 PENIS INJURY 10
258 PERIPHERAL SWELLING 10
259 PRODUCTIVE COUGH 10
260 PROSTATIC SPECIFIC ANTIGEN INCREASED 10
261 PULMONARY CONGESTION 10
262 SKIN DISCOLOURATION 10
263 ANGIOPATHY 9
264 BLADDER CANCER 9
265 BLISTER 9
266 BLOOD POTASSIUM INCREASED 9
267 CANDIDA INFECTION 9
268 CARDIAC DISORDER 9
269 CATARACT 9
270 COVID-19 9
271 CYANOSIS 9
272 DEVICE DEFECTIVE 9
273 DIALYSIS 9
274 DRUG DISPENSING ERROR 9
275 HAEMATOCHEZIA 9
276 HAEMATOMA 9
277 HAEMODIALYSIS 9
278 HERPES ZOSTER 9
279 HOT FLUSH 9
280 HYPONATRAEMIA 9
281 INJURY 9
282 MALIGNANT MELANOMA 9
283 MULTI-ORGAN FAILURE 9
284 POOR QUALITY DRUG ADMINISTERED 9
285 PRODUCT ADMINISTRATION ERROR 9
286 RASH ERYTHEMATOUS 9
287 RED BLOOD CELL COUNT DECREASED 9
288 RENAL FAILURE ACUTE 9
289 SOMNOLENCE 9
290 STAPHYLOCOCCAL INFECTION 9
291 STEVENS-JOHNSON SYNDROME 9
292 THERAPEUTIC RESPONSE DECREASED 9
293 THROMBOTIC MICROANGIOPATHY 9
294 ACCIDENTAL EXPOSURE TO PRODUCT 8
295 ACUTE MYOCARDIAL INFARCTION 8
296 ACUTE PULMONARY OEDEMA 8
297 ANAPHYLACTIC SHOCK 8
298 ARTERIAL OCCLUSIVE DISEASE 8
299 ASPHYXIA 8
300 ATAXIA 8
301 BACTERIAL INFECTION 8
302 BLINDNESS 8
303 BLOOD TESTOSTERONE DECREASED 8
304 CARDIAC SEPTAL HYPERTROPHY 8
305 DELAYED GRAFT FUNCTION 8
306 DELIRIUM 8
307 DEPRESSED MOOD 8
308 DISORIENTATION 8
309 DIZZINESS POSTURAL 8
310 ELECTROCARDIOGRAM QT PROLONGED 8
311 EPISTAXIS 8
312 FEELING HOT 8
313 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8
314 HAEMATOCRIT DECREASED 8
315 HYPOGLYCAEMIA 8
316 HYPOPROTEINAEMIA 8
317 INCORRECT PRODUCT STORAGE 8
318 INJECTION SITE BRUISING 8
319 INJECTION SITE ERYTHEMA 8
320 INTERNATIONAL NORMALISED RATIO INCREASED 8
321 LEG AMPUTATION 8
322 LIVER FUNCTION TEST ABNORMAL 8
323 MATERNAL EXPOSURE DURING PREGNANCY 8
324 MENIERE^S DISEASE 8
325 METABOLIC ACIDOSIS 8
326 MOTOR DYSFUNCTION 8
327 NASOPHARYNGITIS 8
328 NEONATAL HYPOXIA 8
329 NEPHROGENIC ANAEMIA 8
330 NEUROPATHY PERIPHERAL 8
331 OEDEMA 8
332 PANCREATITIS ACUTE 8
333 PANCYTOPENIA 8
334 PERIPHERAL ISCHAEMIA 8
335 PEYRONIE'S DISEASE 8
336 POLLAKIURIA 8
337 PRODUCT PREPARATION ERROR 8
338 PRODUCT SOLUBILITY ABNORMAL 8
339 RENAL DISORDER 8
340 RHABDOMYOLYSIS 8
341 SKIN NECROSIS 8
342 SLEEP DISORDER 8
343 STRESS 8
344 SUICIDAL IDEATION 8
345 SUPRAVENTRICULAR TACHYCARDIA 8
346 TONGUE INJURY 8
347 URETHRAL HAEMORRHAGE 8
348 URTICARIA 8
349 VENTRICULAR TACHYCARDIA 8
350 VISION BLURRED 8
351 ABDOMINAL DISCOMFORT 7
352 ABSCESS 7
353 ARTHRITIS 7
354 BLOOD GLUCOSE DECREASED 7
355 CARDIO-RESPIRATORY ARREST 7
356 CARDIOVASCULAR DISORDER 7
357 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7
358 DEVICE DIFFICULT TO USE 7
359 DEVICE USE ISSUE 7
360 DRUG RESISTANCE 7
361 FACIAL BONES FRACTURE 7
362 GRAFT VERSUS HOST DISEASE 7
363 GROIN PAIN 7
364 HAEMORRHAGE INTRACRANIAL 7
365 HEART RATE DECREASED 7
366 HEPATIC FAILURE 7
367 HEPATIC FIBROSIS 7
368 HYPERURICAEMIA 7
369 INJECTION SITE DISCOMFORT 7
370 INJECTION SITE INJURY 7
371 ISCHAEMIA 7
372 MACULAR OEDEMA 7
373 MENTAL DISORDER 7
374 MUCOCUTANEOUS ULCERATION 7
375 MYELOSUPPRESSION 7
376 NEURALGIA 7
377 NO THERAPEUTIC RESPONSE 7
378 PERITONITIS 7
379 PO2 DECREASED 7
380 PRODUCT USE COMPLAINT 7
381 PROSTATECTOMY 7
382 PROSTATIC DISORDER 7
383 PROTHROMBIN TIME PROLONGED 7
384 PULMONARY HAEMORRHAGE 7
385 PULMONARY HYPERTENSION 7
386 RENAL INJURY 7
387 RESPIRATORY ARREST 7
388 RESPIRATORY RATE INCREASED 7
389 SYSTOLIC HYPERTENSION 7
390 TINNITUS 7
391 UNEVALUABLE EVENT 7
392 URINARY INCONTINENCE 7
393 VENOOCCLUSIVE LIVER DISEASE 7
394 VENTRICULAR EXTRASYSTOLES 7
395 VENTRICULAR FIBRILLATION 7
396 VERTIGO 7
397 ADVERSE DRUG REACTION 6
398 AMPUTATION 6
399 ARM AMPUTATION 6
400 ARTERIOSPASM CORONARY 6
401 ATRIOVENTRICULAR BLOCK 6
402 BK VIRUS INFECTION 6
403 BLOOD LACTATE DEHYDROGENASE INCREASED 6
404 CHRONIC GRAFT VERSUS HOST DISEASE 6
405 COMA 6
406 DEHYDRATION 6
407 DEVICE DELIVERY SYSTEM ISSUE 6
408 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6
409 DYSPEPSIA 6
410 ECCHYMOSIS 6
411 FEVER NEONATAL 6
412 FOETAL EXPOSURE DURING PREGNANCY 6
413 GASTRITIS 6
414 HAEMORRHOIDS 6
415 HYPERKALAEMIA 6
416 HYPOXIA 6
417 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6
418 INFLAMMATION 6
419 INFLUENZA 6
420 INJECTION SITE DISCOLOURATION 6
421 INJECTION SITE MASS 6
422 INTESTINAL OBSTRUCTION 6
423 LIQUID PRODUCT PHYSICAL ISSUE 6
424 MYOPATHY 6
425 NEONATAL APNOEIC ATTACK 6
426 NEUTROPHIL COUNT DECREASED 6
427 NIGHT SWEATS 6
428 OROPHARYNGEAL PAIN 6
429 PATHOGEN RESISTANCE 6
430 PRODUCT DOSE OMISSION ISSUE 6
431 PRODUCT LABEL ISSUE 6
432 PROTEINURIA 6
433 RESPIRATORY DISTRESS 6
434 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6
435 THERAPEUTIC RESPONSE UNEXPECTED 6
436 TOE AMPUTATION 6
437 TREATMENT NONCOMPLIANCE 6
438 URINE OUTPUT DECREASED 6
439 VASCULITIS NECROTISING 6
440 VIRAL MUTATION IDENTIFIED 6
441 WHEEZING 6
442 WOUND COMPLICATION 6
443 ACCIDENTAL OVERDOSE 5
444 ALTERED STATE OF CONSCIOUSNESS 5
445 ANHEDONIA 5
446 BLOOD CREATINE INCREASED 5
447 BLOOD CREATININE DECREASED 5
448 BLOOD POTASSIUM DECREASED 5
449 BLOOD PRESSURE ABNORMAL 5
450 BONE MARROW FAILURE 5
451 BRONCHITIS 5
452 CARDIAC OPERATION 5
453 CARDIOGENIC SHOCK 5
454 CARDIOMYOPATHY 5
455 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5
456 COLITIS 5
457 DEVICE OCCLUSION 5
458 DIABETIC KETOACIDOSIS 5
459 DRUG ADMINISTERED AT INAPPROPRIATE SITE 5
460 DRUG DOSE OMISSION BY DEVICE 5
461 EJACULATION FAILURE 5
462 EJECTION FRACTION DECREASED 5
463 EXPOSURE DURING PREGNANCY 5
464 FEAR 5
465 FOREIGN BODY 5
466 FOREIGN BODY TRAUMA 5
467 GLOMERULAR FILTRATION RATE DECREASED 5
468 HAEMATEMESIS 5
469 HAEMODYNAMIC INSTABILITY 5
470 HARLEQUIN SKIN REACTION 5
471 HEPATITIS 5
472 HYDRONEPHROSIS 5
473 IMMUNOSUPPRESSION 5
474 IRON DEFICIENCY ANAEMIA 5
475 IRRITABILITY 5
476 LABORATORY TEST ABNORMAL 5
477 LOWER RESPIRATORY TRACT INFECTION FUNGAL 5
478 LYMPHOMA 5
479 MEDICAL DEVICE COMPLICATION 5
480 MULTIPLE SCLEROSIS 5
481 MULTIPLE USE OF SINGLE-USE PRODUCT 5
482 MUSCULOSKELETAL DISCOMFORT 5
483 MYOSITIS 5
484 NASAL CONGESTION 5
485 NEONATAL DISORDER 5
486 NERVOUSNESS 5
487 NEUROTOXICITY 5
488 NOCTURIA 5
489 OSTEOPENIA 5
490 PARALYSIS 5
491 PENILE CONTUSION 5
492 PERICARDIAL EFFUSION 5
493 PERIOSTITIS 5
494 PERIPHERAL VASCULAR DISORDER 5
495 PNEUMOTHORAX 5
496 POOR QUALITY DEVICE USED 5
497 POOR QUALITY PRODUCT ADMINISTERED 5
498 PORTAL VEIN THROMBOSIS 5
499 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 5
500 PRESYNCOPE 5
501 PROCTALGIA 5
502 PRODUCT COMMUNICATION ISSUE 5
503 PRODUCT PACKAGING ISSUE 5
504 PRODUCT PREPARATION ISSUE 5
505 RENAL CYST 5
506 RESPIRATORY DISORDER 5
507 RESTLESSNESS 5
508 RHINORRHOEA 5
509 SINUSITIS 5
510 STAPHYLOCOCCAL SEPSIS 5
511 SUBARACHNOID HAEMORRHAGE 5
512 SURGERY 5
513 SWELLING FACE 5
514 TARDIVE DYSKINESIA 5
515 THROMBOTIC THROMBOCYTOPENIC PURPURA 5
516 TOXIC SKIN ERUPTION 5
517 TRANSPLANT REJECTION 5
518 TREATMENT FAILURE 5
519 TYPE 2 DIABETES MELLITUS 5
520 ULCER 5
521 UNRESPONSIVE TO STIMULI 5
522 URETHRAL PAIN 5
523 WOUND 5
524 WOUND INFECTION 5
525 ABASIA 4
526 ACTIVITIES OF DAILY LIVING IMPAIRED 4
527 ACUTE CORONARY SYNDROME 4
528 ACUTE RESPIRATORY DISTRESS SYNDROME 4
529 AGRANULOCYTOSIS 4
530 ANGER 4
531 ANOREXIA 4
532 ANORGASMIA 4
533 ANURIA 4
534 AORTIC VALVE INCOMPETENCE 4
535 APPLICATION SITE PAIN 4
536 ARTERIOSCLEROSIS CORONARY ARTERY 4
537 ARTERIOSCLEROSIS OBLITERANS 4
538 ATELECTASIS 4
539 BASILAR ARTERY OCCLUSION 4
540 BENIGN PROSTATIC HYPERPLASIA 4
541 BLOOD SODIUM DECREASED 4
542 BODY TEMPERATURE DECREASED 4
543 BONE DENSITY DECREASED 4
544 BRONCHOPULMONARY ASPERGILLOSIS 4
545 CARDIAC FAILURE ACUTE 4
546 CARDIAC OUTPUT DECREASED 4
547 CARDIOMEGALY 4
548 CONVULSION NEONATAL 4
549 CYANOPSIA 4
550 CYTOMEGALOVIRUS TEST POSITIVE 4
551 DEVICE RELATED INFECTION 4
552 DEVICE USE ERROR 4
553 DISEASE RECURRENCE 4
554 DISTURBANCE IN ATTENTION 4
555 DRUG EFFECT DELAYED 4
556 DRUG EFFECT INCREASED 4
557 DRUG INTOLERANCE 4
558 DYSGEUSIA 4
559 DYSPNOEA EXERTIONAL 4
560 DYSTONIA 4
561 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4
562 ENCEPHALOPATHY 4
563 EXFOLIATIVE RASH 4
564 EXPOSURE VIA SKIN CONTACT 4
565 EYE DISORDER 4
566 FACE OEDEMA 4
567 FEBRILE NEUTROPENIA 4
568 GASTRIC HAEMORRHAGE 4
569 GASTROENTERITIS 4
570 GASTROOESOPHAGEAL REFLUX DISEASE 4
571 GENITAL BURNING SENSATION 4
572 GLAUCOMA 4
573 GYNAECOMASTIA 4
574 HAEMOLYTIC ANAEMIA 4
575 HALLUCINATION, VISUAL 4
576 HICCUPS 4
577 HYPERBILIRUBINAEMIA 4
578 HYPERPARATHYROIDISM SECONDARY 4
579 ILLNESS 4
580 IMPAIRED HEALING 4
581 INFUSION RELATED REACTION 4
582 INJECTION SITE SWELLING 4
583 INTESTINAL HAEMORRHAGE 4
584 LIMB INJURY 4
585 LIP SWELLING 4
586 LOSS OF LIBIDO 4
587 LUNG NEOPLASM MALIGNANT 4
588 MALIGNANT NEOPLASM PROGRESSION 4
589 MASS 4
590 MICTURITION URGENCY 4
591 MIGRAINE 4
592 MITRAL VALVE INCOMPETENCE 4
593 MOOD ALTERED 4
594 MUSCLE ATROPHY 4
595 NECK PAIN 4
596 NEONATAL HYPONATRAEMIA 4
597 OBSTRUCTION GASTRIC 4
598 OBSTRUCTIVE AIRWAYS DISORDER 4
599 OESOPHAGITIS 4
600 OPTIC ISCHAEMIC NEUROPATHY 4
601 OSTEOPOROSIS 4
602 PARESIS 4
603 PEMPHIGOID 4
604 PENILE DISCOMFORT 4
605 PENIS DEVIATION 4
606 PERIPHERAL COLDNESS 4
607 PNEUMONIA ASPIRATION 4
608 PNEUMONIA STAPHYLOCOCCAL 4
609 PRODUCT COMPLAINT 4
610 PRODUCT CONTAINER ISSUE 4
611 PRODUCT LABEL CONFUSION 4
612 PROSTATITIS 4
613 PROSTATOMEGALY 4
614 PULMONARY SARCOIDOSIS 4
615 RASH PRURITIC 4
616 SCAR 4
617 SENSORY LOSS 4
618 SHUNT STENOSIS 4
619 SKIN DISORDER 4
620 STILLBIRTH 4
621 TENDERNESS 4
622 TRANSAMINASES INCREASED 4
623 TRANSIENT GLOBAL AMNESIA 4
624 TRICUSPID VALVE INCOMPETENCE 4
625 UPPER GASTROINTESTINAL HAEMORRHAGE 4
626 URETERIC STENOSIS 4
627 VEIN DISORDER 4
628 VENTRICULAR HYPERTROPHY 4
629 VESSEL PUNCTURE SITE HAEMATOMA 4
630 VISUAL ACUITY REDUCED 4
631 ABDOMINAL HERNIA 3
632 ABNORMAL BEHAVIOUR 3
633 ABORTION SPONTANEOUS 3
634 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3
635 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3
636 AGGRESSION 3
637 AGITATION 3
638 ALANINE AMINOTRANSFERASE DECREASED 3
639 ALOPECIA 3
640 ANGINA UNSTABLE 3
641 ANGIOEDEMA 3
642 ANTITHROMBIN III DECREASED 3
643 AORTIC ANEURYSM 3
644 APGAR SCORE LOW 3
645 APHASIA 3
646 BLOOD ALBUMIN INCREASED 3
647 BLOOD BLISTER 3
648 BLOOD CALCIUM DECREASED 3
649 BLOOD CHOLESTEROL DECREASED 3
650 BLOOD GLUCOSE FLUCTUATION 3
651 BLOOD PRESSURE FLUCTUATION 3
652 BLOOD PRESSURE SYSTOLIC INCREASED 3
653 BLOOD SODIUM INCREASED 3
654 BLOOD THYROID STIMULATING HORMONE INCREASED 3
655 BLOOD URIC ACID INCREASED 3
656 BODY HEIGHT DECREASED 3
657 BONE DISORDER 3
658 BONE PAIN 3
659 BRAIN OEDEMA 3
660 BURSITIS 3
661 CARDIAC FAILURE CHRONIC 3
662 CARDIAC MURMUR 3
663 CEREBRAL HAEMATOMA 3
664 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3
665 CONTINUOUS HAEMODIAFILTRATION 3
666 CYSTITIS VIRAL 3
667 DEAFNESS NEUROSENSORY 3
668 DECUBITUS ULCER 3
669 DEPENDENCE 3
670 DEVICE CONNECTION ISSUE 3
671 DEVICE PHYSICAL PROPERTY ISSUE 3
672 DILATATION VENTRICULAR 3
673 DRUG ABUSE 3
674 DRUG DOSE OMISSION 3
675 DRUG TOLERANCE 3
676 DRY EYE 3
677 DUODENAL ULCER 3
678 DYSKINESIA 3
679 DYSPAREUNIA 3
680 ELECTROLYTE IMBALANCE 3
681 ENTEROBACTER INFECTION 3
682 EPSTEIN-BARR VIRAEMIA 3
683 EPSTEIN-BARR VIRUS INFECTION 3
684 ESCHERICHIA INFECTION 3
685 EXPOSURE VIA PARTNER 3
686 EXTRASYSTOLES 3
687 FAT EMBOLISM 3
688 FEAR OF INJECTION 3
689 FEELING COLD 3
690 FEMUR FRACTURE 3
691 FIBROSIS 3
692 FLATULENCE 3
693 FRUSTRATION TOLERANCE DECREASED 3
694 GALLBLADDER DISORDER 3
695 GASTRIC ULCER 3
696 GASTRITIS EROSIVE 3
697 GENITAL RASH 3
698 HAEMORRHAGIC DIATHESIS 3
699 HAIR GROWTH ABNORMAL 3
700 HEAD INJURY 3
701 HEPATECTOMY 3
702 HEPATIC NEOPLASM MALIGNANT 3
703 HEPATITIS B 3
704 HIGH DENSITY LIPOPROTEIN INCREASED 3
705 HYPERGLYCAEMIA 3
706 HYPOVOLAEMIC SHOCK 3
707 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3
708 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3
709 INCISION SITE IMPAIRED HEALING 3
710 INCORRECT STORAGE OF DRUG 3
711 INJECTION SITE INDURATION 3
712 INTESTINAL ISCHAEMIA 3
713 INTRAOCULAR PRESSURE INCREASED 3
714 INTRAVENTRICULAR HAEMORRHAGE 3
715 JAUNDICE 3
716 JOINT STIFFNESS 3
717 KIDNEY INFECTION 3
718 KLEBSIELLA SEPSIS 3
719 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3
720 LACTIC ACIDOSIS 3
721 LIBIDO DECREASED 3
722 LIBIDO DISORDER 3
723 LUNG INFILTRATION 3
724 LYMPHADENOPATHY 3
725 LYMPHOPROLIFERATIVE DISORDER 3
726 MOBILITY DECREASED 3
727 MOUTH ULCERATION 3
728 MOVEMENT DISORDER 3
729 MUCORMYCOSIS 3
730 MULTIPLE MYELOMA 3
731 MUSCLE SWELLING 3
732 MYDRIASIS 3
733 MYOCARDITIS 3
734 NECROTISING COLITIS 3
735 NEONATAL HYPOTENSION 3
736 NEOPLASM RECURRENCE 3
737 NERVE INJURY 3
738 NEUROPATHY 3
739 ORAL PAIN 3
740 ORTHOSTATIC HYPOTENSION 3
741 OSTEONECROSIS 3
742 PANCREATITIS 3
743 PANNICULITIS 3
744 PARAPLEGIA 3
745 PENILE ERYTHEMA 3
746 PENILE NECROSIS 3
747 PENILE ULCERATION 3
748 PHARYNGITIS 3
749 PHIMOSIS 3
750 PHOTOSENSITIVITY REACTION 3
751 PLATELET COUNT INCREASED 3
752 PNEUMONIA BACTERIAL 3
753 PNEUMONIA FUNGAL 3
754 PNEUMONITIS 3
755 POOR PERIPHERAL CIRCULATION 3
756 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3
757 POSTOPERATIVE WOUND COMPLICATION 3
758 POSTOPERATIVE WOUND INFECTION 3
759 PRESCRIBED UNDERDOSE 3
760 PROCEDURAL COMPLICATION 3
761 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3
762 PRODUCT PHYSICAL CONSISTENCY ISSUE 3
763 PRODUCT PHYSICAL ISSUE 3
764 PRODUCT PRESCRIBING ISSUE 3
765 PROTEIN TOTAL DECREASED 3
766 PSEUDOMONAL SEPSIS 3
767 PULMONARY ARTERIAL HYPERTENSION 3
768 PULMONARY FIBROSIS 3
769 PULMONARY HYPERTENSIVE CRISIS 3
770 PULMONARY HYPOPLASIA 3
771 PUPILLARY REFLEX IMPAIRED 3
772 RALES 3
773 RASH GENERALISED 3
774 RASH PAPULAR 3
775 RECTAL HAEMORRHAGE 3
776 SCLEREMA 3
777 SCROTAL PAIN 3
778 SKIN CANCER 3
779 SPEECH DISORDER 3
780 SPUTUM DISCOLOURED 3
781 SUDDEN DEATH 3
782 SUICIDE ATTEMPT 3
783 SUSPECTED OFF LABEL USE 3
784 SYSTEMIC LUPUS ERYTHEMATOSUS 3
785 SYSTOLIC DYSFUNCTION 3
786 TESTICULAR DISORDER 3
787 TESTICULAR SWELLING 3
788 THERAPEUTIC PRODUCT EFFECT INCREASED 3
789 THERAPY PARTIAL RESPONDER 3
790 THROAT IRRITATION 3
791 THROMBOANGIITIS OBLITERANS 3
792 THROMBOPHLEBITIS 3
793 TONGUE DISORDER 3
794 TOXICITY TO VARIOUS AGENTS 3
795 TRANSIENT ISCHAEMIC ATTACK 3
796 TRAUMATIC LUNG INJURY 3
797 TROPONIN INCREASED 3
798 UPPER LIMB FRACTURE 3
799 URETERIC OBSTRUCTION 3
800 URETHRAL STENOSIS 3
801 URINE ANALYSIS ABNORMAL 3
802 VASCULAR INJURY 3
803 VASCULITIS 3
804 VENOOCCLUSIVE DISEASE 3
805 VENOUS THROMBOSIS 3
806 VENTRICULAR DYSFUNCTION 3
807 VIRAL INFECTION 3
808 VISUAL FIELD DEFECT 3
809 VULVOVAGINAL BURNING SENSATION 3
810 WRONG PRODUCT ADMINISTERED 3
811 WRONG STRENGTH 3
812 ABDOMINAL PAIN LOWER 2
813 ABNORMAL DREAMS 2
814 ACCIDENT 2
815 ACCIDENTAL NEEDLE STICK 2
816 ACIDOSIS 2
817 ACTINIC KERATOSIS 2
818 ACUTE LEFT VENTRICULAR FAILURE 2
819 ACUTE LEUKAEMIA 2
820 ACUTE RESPIRATORY FAILURE 2
821 AGEUSIA 2
822 ANAESTHETIC COMPLICATION 2
823 ANAL ABSCESS 2
824 ANAL CANCER 2
825 ANAL INCONTINENCE 2
826 ANAPHYLACTOID REACTION 2
827 ANEURYSM 2
828 AORTIC ANEURYSM RUPTURE 2
829 AORTIC STENOSIS 2
830 AORTIC VALVE DISEASE 2
831 APPENDICITIS 2
832 ARTERIAL STENOSIS 2
833 ARTERIAL THROMBOSIS 2
834 ARTHROPATHY 2
835 ASPERGILLOSIS 2
836 ASTHMA 2
837 ATRIAL FLUTTER 2
838 BACTERAEMIA 2
839 BACTERIAL SEPSIS 2
840 BALANCE DISORDER 2
841 BALANITIS 2
842 BARRETT'S OESOPHAGUS 2
843 BASE EXCESS NEGATIVE 2
844 BLADDER CANCER STAGE IV 2
845 BLADDER DISORDER 2
846 BLINDNESS UNILATERAL 2
847 BLOOD BILIRUBIN DECREASED 2
848 BLOOD CALCIUM INCREASED 2
849 BLOOD CHLORIDE INCREASED 2
850 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2
851 BLOOD OESTROGEN INCREASED 2
852 BLOOD PH INCREASED 2
853 BLOOD PHOSPHORUS INCREASED 2
854 BLOOD URINE 2
855 BLOODY DISCHARGE 2
856 BONE HYPERTROPHY 2
857 BRADYCARDIA NEONATAL 2
858 BRAIN DEATH 2
859 BRAIN HERNIATION 2
860 BRAIN INJURY 2
861 BRAIN NATRIURETIC PEPTIDE INCREASED 2
862 BRONCHOSPASM 2
863 BUNDLE BRANCH BLOCK RIGHT 2
864 CAPILLARY FRAGILITY INCREASED 2
865 CARDIAC ARREST NEONATAL 2
866 CARDIAC VENTRICULAR THROMBOSIS 2
867 CAROTID ARTERIOSCLEROSIS 2
868 CAROTID ARTERY OCCLUSION 2
869 CAROTID ARTERY STENOSIS 2
870 CAROTID ARTERY THROMBOSIS 2
871 CARPAL TUNNEL SYNDROME 2
872 CARTILAGE HYPERTROPHY 2
873 CATARACT OPERATION 2
874 CEREBRAL ARTERY EMBOLISM 2
875 CEREBRAL DISORDER 2
876 CEREBRAL VASOCONSTRICTION 2
877 CHOLECYSTECTOMY 2
878 CHOLECYSTITIS ACUTE 2
879 CHROMATURIA 2
880 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2
881 CLOSTRIDIUM DIFFICILE COLITIS 2
882 COLITIS ULCERATIVE 2
883 COLONIC POLYP 2
884 COMPARTMENT SYNDROME 2
885 COMPUTERISED TOMOGRAM HEART ABNORMAL 2
886 CONGENITAL PULMONARY VALVE ATRESIA 2
887 CONGESTIVE CARDIOMYOPATHY 2
888 CORONARY ARTERY OCCLUSION 2
889 CORONARY ARTERY STENOSIS 2
890 CRANIOFACIAL FRACTURE 2
891 CYST 2
892 CYTOKINE RELEASE SYNDROME 2
893 CYTOPENIA 2
894 DEAFNESS UNILATERAL 2
895 DECREASED ACTIVITY 2
896 DEVICE INEFFECTIVE 2
897 DIABETES INSIPIDUS 2
898 DIABETES MELLITUS INADEQUATE CONTROL 2
899 DISSEMINATED TUBERCULOSIS 2
900 DIVERTICULITIS 2
901 DRUG ERUPTION 2
902 DRUG LEVEL INCREASED 2
903 DRUG TITRATION ERROR 2
904 DRUG TOXICITY 2
905 DUCTUS ARTERIOSUS PREMATURE CLOSURE 2
906 DUODENAL ULCER HAEMORRHAGE 2
907 DYSAESTHESIA 2
908 DYSPHAGIA 2
909 DYSSTASIA 2
910 ECONOMIC PROBLEM 2
911 ECTOPIC PREGNANCY 2
912 ECZEMA 2
913 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2
914 EMOTIONAL DISORDER 2
915 ENDOTHELIAL DYSFUNCTION 2
916 ENDOTOXIC SHOCK 2
917 ENTERITIS 2
918 EOSINOPHIL PERCENTAGE INCREASED 2
919 EOSINOPHILIA 2
920 EPIDIDYMITIS 2
921 ERUCTATION 2
922 ERYTHEMA MULTIFORME 2
923 EXOSTOSIS 2
924 EXTREMITY NECROSIS 2
925 EYE DISCHARGE 2
926 EYE INFLAMMATION 2
927 EYE IRRITATION 2
928 EYE PAIN 2
929 EYELID OEDEMA 2
930 FAECES DISCOLOURED 2
931 FEEDING INTOLERANCE 2
932 FEELING OF DESPAIR 2
933 FIBRIN D DIMER INCREASED 2
934 FINE MOTOR SKILL DYSFUNCTION 2
935 FISTULA 2
936 FLUID RETENTION 2
937 FOETAL GROWTH RESTRICTION 2
938 FOLLICULITIS 2
939 FOOT FRACTURE 2
940 FORMICATION 2
941 FRACTURE 2
942 FRACTURE OF PENIS 2
943 FRUSTRATION 2
944 GALLBLADDER OPERATION 2
945 GASTRIC DISORDER 2
946 GASTRIC MUCOSAL HYPERTROPHY 2
947 GENERAL PHYSICAL CONDITION ABNORMAL 2
948 GENERALISED ERYTHEMA 2
949 GENITAL PAIN 2
950 GENITAL PARAESTHESIA 2
951 GLOSSODYNIA 2
952 GLYCOSYLATED HAEMOGLOBIN INCREASED 2
953 GRAFT VERSUS HOST DISEASE IN LIVER 2
954 GRAND MAL CONVULSION 2
955 GRANULOCYTE COUNT INCREASED 2
956 GRIP STRENGTH DECREASED 2
957 HAEMATOLOGICAL MALIGNANCY 2
958 HAEMOGLOBIN INCREASED 2
959 HAEMOLYSIS 2
960 HAEMOLYTIC URAEMIC SYNDROME 2
961 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2
962 HEMIPARESIS 2
963 HENOCH-SCHONLEIN PURPURA 2
964 HEPATIC CANCER STAGE IV 2
965 HEPATIC CIRRHOSIS 2
966 HEPATITIS FULMINANT 2
967 HEPATITIS TOXIC 2
968 HEPATOMEGALY 2
969 HEPATORENAL SYNDROME 2
970 HIATUS HERNIA 2
971 HISTIOCYTOSIS HAEMATOPHAGIC 2
972 HORMONE LEVEL ABNORMAL 2
973 HOSPITALISATION 2
974 HYPERAMYLASAEMIA 2
975 HYPERCHOLESTEROLAEMIA 2
976 HYPERPARATHYROIDISM 2
977 HYPOAESTHESIA ORAL 2
978 HYPOCALCAEMIA 2
979 HYPOTHALAMO-PITUITARY DISORDER 2
980 HYPOTONIA 2
981 ILEUS PARALYTIC 2
982 ILIAC ARTERY OCCLUSION 2
983 ILL-DEFINED DISORDER 2
984 IMPAIRED GASTRIC EMPTYING 2
985 INCISION SITE HAEMORRHAGE 2
986 INCORRECT PRODUCT ADMINISTRATION DURATION 2
987 INCORRECT ROUTE OF DRUG ADMINISTRATION 2
988 INFUSION SITE EXTRAVASATION 2
989 INJECTION SITE EXTRAVASATION 2
990 INJECTION SITE INFLAMMATION 2
991 INJECTION SITE IRRITATION 2
992 INTRACARDIAC THROMBUS 2
993 JOINT SWELLING 2
994 KNEE OPERATION 2
995 LABELLED DRUG-DRUG INTERACTION ISSUE 2
996 LEFT VENTRICULAR FAILURE 2
997 LIVER FUNCTION TEST INCREASED 2
998 LIVER INJURY 2
999 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2